Committed to Healthier Life

Aurobindo Pharma Ltd. is committed to making a difference in the lives of millions of people by making medicines affordable and accessible for them across the globe.

Hon'ble Prime Minister
Shri Narendra Modi

Inaugurated our flagship Penicillin-G Facility at Kakinada,
Andhra Pradesh

One of the largest
Pharmaceutical Company

With a portfolio of 830 US ANDAs fillings

Delivering high quality biosimilars

We have a strong and sustainable pipeline of high value biosimilar programs with a primary focus on Oncology and Immunology therapeutic segments.

Annual Report

To access the comprehensive details of our annual performance, please click the link below to view our annual report.

Corporate Social Responsibility

Aurobindo Pharma Foundation, the philanthropic arm of Aurobindo Pharma Limited, strives to transform and uplift the lives of underserved communities.

Crafting a Responsible Tomorrow

Aurobindo Pharma commits itself to creating a more equitable and inclusive society by supporting processes that lead to a sustainable transformation.

Life @ Aurobindo

The culture at Aurobindo is one of learning, collaboration, inclusivity with unlimited opportunities for our employees

A global footprint of excellence

Our Key Subsidiaries

Delivering exceptional value to all our consumers worldwide

Manufacturing Prowess

Our 29 manufacturing facilities across the globe have a manufacturing capacities of 50+ billion formulations units and 19,000+ MT APIs. and have advanced vertical integration to produce finished formulation products at an affordable price.

Global Presence

We are present across 150+ global markets including the US, Europe and Growth Markets, and are ranked amongst the top 10*** generic companies across eight countries in Europe.

Research & Development

Steadfast in our commitment to innovation & research, we invest significantly in our R&D. 830 filings for ANDAs in the US, with 600+ approvals for the same.

News & Updates

Oct

Press Release - Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg

Sep

Press Release - Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business

Sep

Press Release - Aurobindo Pharma receives USFDA Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg

STAY CONNECTED

* Largest generic Pharma Company in the US (by Rx dispensed as per MAT March 2024)
** Global workforce including both permanent employees and contractual workers
*** Source: IQVIA data MAT Q3 2024